These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23276996)

  • 1. Regulatory issues in management of chemicals in OECD member countries.
    Kleandrova VV; Speck-Planche A
    Front Biosci (Elite Ed); 2013 Jan; 5(1):375-98. PubMed ID: 23276996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory assessment of chemicals within OECD member countries, EU and in Russia.
    Fjodorova N; Novich M; Vrachko M; Kharchevnikova N; Zholdakova Z; Sinitsyna O; Benfenati E
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(1):40-88. PubMed ID: 18322867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directions in QSAR modeling for regulatory uses in OECD member countries, EU and in Russia.
    Fjodorova N; Novich M; Vrachko M; Smirnov V; Kharchevnikova N; Zholdakova Z; Novikov S; Skvortsova N; Filimonov D; Poroikov V; Benfenati E
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(2):201-36. PubMed ID: 18569330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Legal aspects of the REACH regulation. The control system of the REACH regulation--new approaches in the EU chemical legislation].
    Pache E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1408-16. PubMed ID: 19137216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Background of REACH in EU regulations on evaluation of chemicals.
    Foth H; Hayes A
    Hum Exp Toxicol; 2008 Jun; 27(6):443-61. PubMed ID: 18784197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The European Union's REACH regulation: a review of its history and requirements.
    Williams ES; Panko J; Paustenbach DJ
    Crit Rev Toxicol; 2009; 39(7):553-75. PubMed ID: 19650717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR Use in REACH Analyses of Alternatives to Predict Human Health and Environmental Toxicity of Alternative Chemical Substances.
    Chinen K; Malloy T
    Integr Environ Assess Manag; 2020 Sep; 16(5):745-760. PubMed ID: 32162772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated testing and intelligent assessment-new challenges under REACH.
    Ahlers J; Stock F; Werschkun B
    Environ Sci Pollut Res Int; 2008 Oct; 15(7):565-72. PubMed ID: 18818964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Integrated Assessment Scheme for assessing the adequacy of (eco)toxicological data under REACH.
    Hulzebos E; Gunnarsdottir S; Rila JP; Dang Z; Rorije E
    Toxicol Lett; 2010 Oct; 198(2):255-62. PubMed ID: 20633615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk assessment and chemical safety under REACH].
    Foth H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1387-97. PubMed ID: 19137214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The REACH legislation: the consumer and environment protection perspective].
    Gundert-Remy U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1426-33. PubMed ID: 19137218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of REACH Annex IV--establishing the minimum risk of a substance based on its intrinsic properties.
    Blainey M; Avila Cd; van der Zandt P
    Regul Toxicol Pharmacol; 2010 Feb; 56(1):111-20. PubMed ID: 19788906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk assessment of nanomaterials in cosmetics: a European union perspective.
    Henkler F; Tralau T; Tentschert J; Kneuer C; Haase A; Platzek T; Luch A; Götz ME
    Arch Toxicol; 2012 Nov; 86(11):1641-6. PubMed ID: 23052193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Responsibilities of the European Chemical Agency under REACH].
    Foth H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1398-407. PubMed ID: 19137215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating process safety with molecular modeling-based risk assessment of chemicals within the REACH regulatory framework: benefits and future challenges.
    Lewis A; Kazantzis N; Fishtik I; Wilcox J
    J Hazard Mater; 2007 Apr; 142(3):592-602. PubMed ID: 16930827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicological comments to the discussion about REACH.
    Greim H; Arand M; Autrup H; Bolt HM; Bridges J; Dybing E; Glomot R; Foa V; Schulte-Hermann R
    Arch Toxicol; 2006 Mar; 80(3):121-4. PubMed ID: 16411136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A step change towards risk assessment in the 21st century.
    Patlewicz GY; Lander DR
    Front Biosci (Elite Ed); 2013 Jan; 5(2):418-34. PubMed ID: 23276999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alternative methods to animal experiments. What can they afford in the safety testing of chemical substances under REACH?].
    Lilienblum W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1434-43. PubMed ID: 19137219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [REACH: the guidance documents of the European Chemicals Agency (ECHA)].
    Lulei M;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1444-52. PubMed ID: 19137220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PBT assessment using the revised annex XIII of REACH: a comparison with other regulatory frameworks.
    Moermond CT; Janssen MP; de Knecht JA; Montforts MH; Peijnenburg WJ; Zweers PG; Sijm DT
    Integr Environ Assess Manag; 2012 Apr; 8(2):359-71. PubMed ID: 22006646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.